Cell-penetrating peptides (CPPs) are evolving through computational design, stimulus-responsive activation, and targeting modifications to enable precise therapeutic cargo delivery with reduced off-target effects.
Precision cell entryNext-generation CPPs activate only at disease sites and enter only target cells — precision drug delivery at the molecular level
What the researchers found
CPP design evolution: computational/AI design, stimulus-responsive activation (pH/enzyme/light), and targeting modifications enabling precise, cell-type-specific drug delivery with reduced off-target effects.
Why it matters
Getting drugs inside cells is a fundamental barrier. Advanced CPPs that penetrate precisely and only when needed could transform drug delivery.
How the study worked
Review of emerging CPP design strategies covering computational design, responsive activation, and targeting modifications.
What this study cannot tell us
Many advanced CPPs are in preclinical development. Clinical translation of responsive CPPs is complex.
How to read the evidence
Review of design strategies and applications.
When this study was published
Published in 2025.
The bigger picture
CPPs are evolving from indiscriminate cell penetrators to precision delivery tools — the molecular equivalent of guided missiles.
Questions still open
- Which stimulus-responsive mechanism provides the best tumor selectivity?
- Can CPPs deliver large biologics (antibodies) intracellularly?
- Would AI-designed CPPs outperform natural CPPs?
Common questions
How do cell-penetrating peptides deliver drugs?
What makes new CPPs better?
Read the original research
Cell-penetrating peptides for therapeutic applications: emerging design strategies and future directions.
Organic & biomolecular chemistry
Citation
Kim, Eun-Ji; Lee, Yuna; Ryu, Juhee; Kim, Hyemin; Park, Juhee; Lee, Jiyoun. (2026). Cell-penetrating peptides for therapeutic applications: emerging design strategies and future directions.. Organic & biomolecular chemistry. https://doi.org/10.1039/d6ob00146g